Chronic inflammation alters the contribution of neurokinin receptor subtypes to epithelial function in rat colon

Digestive Diseases and Sciences

Volumn 53, Issue 1, 2008, Pages 220-228

  Appleyard, Caroline B ^a   Morales, Marangelie ^a   Santiago, Cariluz ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Colitis; Inflammation; Mucosa; Rat; Tachykinin

Indexed keywords

TACHYKININ RECEPTOR; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC INFLAMMATION; COLON; COLON MUCOSA; COLON SECRETION; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANESTHETICS, LOCAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPSYCHOTIC AGENTS; BENZAMIDES; COLITIS; DISEASE MODELS, ANIMAL; INDOMETHACIN; INTESTINAL MUCOSA; MALE; NEUROKININ A; NEUROTRANSMITTER AGENTS; PIPERIDINES; QUINUCLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, NEUROKININ-3; RECEPTORS, TACHYKININ; STEREOISOMERISM; SUBSTANCE P; TETRODOTOXIN; TRINITROBENZENESULFONIC ACID;

EID: 37249089450     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9847-8     Document Type: Article

References (53)

1. Koch RT, Carney JA, Go VLW (1987) Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 32:369-376
2. Goldin E, Karmeli F, Selinger Z, Rachmilewitz D (1989) Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 35:754-757
3. Maggi CA, Giuliani S, Patacchini R, Quartara L, Rovero P, Renzetti AR, Mizrahi J, Giachetti A (1992) Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum. Gastroenterology 102:88-96
4. Perdue MH, Galbraith R, Davison J (1987) Evidence for substance P as a functional neurotransmitter in guinea pig smooth intestinal mucosa. Regul Pept 18:63-74
5. Holzer P, Holzer-Petsche U (1997) Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther 73:219-263
6. Holzer P, Holzer-Petsche U (2001) Tachykinin receptors in the gut: physiological and pathological implications. Curr Opin Pharmacol 1: 583-590
7. Cooke HJ, Sidhu M, Fox P, Wang YZ, Zimmerman EM (1997) Substance P as a mediator of colonic secretory reflexes. Am J Physiol 272 (Gastrointest Liver Physiol 35):G238-G245
8. Al-Saffar A, Hellstrom PM (2001) Contractile responses to natural tachykinins and selective analogs in normal and inflamed ileal and colonic muscle. Scand J Gastroenterol 36:485-493
9. Riegler M, Castagliuolo I, So PT, Lotz M, Wang C, Wlk M, Sogukoglu T, Cosentini E, Bischof G, Hamilton G, Teleky B, Wenzl E, Matthews JB, Pothoulakis C (1999) Effects of substance P on human colonic mucosa in vitro. Am J Physiol 276 (Gastrointest Liver Physiol 39):G1473-G1483
10. McCafferty DM, Sharkey KA, Wallace JL (1994) Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol 266 (Gastrointest. Liver Physiol 29):G560-G567
11. Pothoulakis C, Castagliuolo I, Lamont JT, Jaffer A, O'Keane JC, Snider RM, Leeman SE (1994) CP-96345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci U S A 91:947-951
12. Moriarty D, Selve N, Baird AW, Goldhill J (2001) Potent NK1 antagonism by SR-140333 reduces rat colonic secretory response to immunocyte activation. Am J Physiol Cell Physiol 49:C852-C858
13. Wormser D, Laufer R, Hart Y, Chorev M, Gilon C, Selinger Z (1986) Highly selective agonists for substance P subtypes. EMBO J 5:2805-2808
14. Drapeau G, D'Orleans-Juste P, Dion S, Rhaleb NE, Rouissi NE, Regoli D (1987) Selective agonists for substance P and neurokinin receptors. Neuropeptides 10:43-54
15. Rovero P, Pestellini V, Patacchini R, Giuliani S, Santicioli P, Maggi CA, Meli A, Giachetti A (1989) A potent and selective agonist for NK-2 tachykinin receptor. Peptides 10:593-595
16. 2) receptor antagonist. Regul Pept 46:31-36
17. Emonds-Alt X, Doutremepuich J-D, Heaulme M, Neliat G, Santucci V, Steinberg R, Vilain P, Bichon D, Ducoux JP, Proietto V (1993) In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol 250:403-413
18. 2 receptor antagonist. Eur J Pharmacol 234:83-90
19. Emonds-Alt X, Bichon D, Ducoux JP (1995) SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci 56:27-32
20. Koelbel CBM, Mayer EA, Reeve JR, Snape WJ, Patel A, Ho FJ (1989) Involvement of substance P in noncholinergic excitation of rabbit colonic muscle. Am J Physiol 256 (Gastrointest. Liver Physiol 19):G246-G253
21. Holzer P, Lippe IT, Heinemann A, Barthó L (1998) Tachykinin NK1 and NK2 receptor-mediated control of peristaltic propulsion in the guinea-pig small intestine in vitro. Neuropharmacology 37:131-138
22. Giuliani S, Tramontana M, Lecci A, Maggi CA (1996) Tachykinin receptors mediate atropine-resistant rat duodenal reflex contractions in vivo. Naunyn Schmiedebergs Arch Pharmacol 354:327-335
23. Vannucchi MG, Faussone-Pellegrini MS (2000) NK1, NK2 and NK3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse. Anat Embryol (Berl) 202:247-255
24. Appleyard CB, Morales M, Percy WH (2006) Regional variations in neurokinin receptor subtype contributions to muscularis mucosae and epithelial function in rat colon. Dig Dis Sci 51:506-516
25. Evangelista S (2001) Involvement of tachykinins in intestinal inflammation. Curr Pharm Des 7:19-30
26. Goode T, O'Connell J, Anton P, Wong H, Reeve J, O'Sullivan GC, Collins JK, Shanahan F (2000) Neurokinin-1 receptor expression in inflammatory bowel disease molecular quantification and localization. Gut 47:387-396
27. Renzi D, Pellegrini B, Tonelli F, Surrenti C, Calabrò A (2000) Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in healthy and inflamed human intestine. Am J Pathol 157:1511-1522
28. Appleyard CB, Wallace JL (1995) Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 269:G119-G125
29. Alberti E, Mikkelsen HB, Larsen JO, Jimenez M (2005) Motility patterns and distribution of interstitial cells of Cajal and nitrergic neurons in the proximal, mid- and distal-colon of the rat. Neurogastroenterol Motil 17:133-147
30. Percy WH, Rose K, Burton MB (1992) Pharmacologic characterization of the muscularis mucosae in three regions of the rabbit colon. J Pharmacol Exp Ther 261:1136-1142
31. Percy WH, Burton MB, Rose K, Donovan V, Burakoff R (1993) In vitro changes in the properties of rabbit colonic muscularis mucosae in colitis. Gastroenterology 104:369-376
32. 2 receptors in the modulation of spontaneous motility in rat proximal colon. Neurogastroenterol Motil 12(5):459-466
33. Elson CO, Sartor RB, Tennyson GS. Riddell RH (1995) Experimental models of inflammatory bowel disease. Gastroenterology 109:1344-1367
34. Jonsson M, Norrgard O, Forsgren S (2005) Substance P and the neurokinin-1 receptor in relation to eosinophilia in ulcerative colitis. Peptides 26:799-814
35. Castagliuolo I, Morteau O, Keates AC, Valenick L, Wang CC, Zacks J, Lu B, Gerard NP, Pothoulakis C (2002) Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor. Br J Pharmacol 136:271-279
36. Di Sebastiano P, Grossi L, Di Mola FF, Angelucci D, Friess H, Marzio L, Innocenti P, Buchler MW (1999) SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig Dis Sci 44:439-444
37. Stucchi AF, Shofer S, Leeman S, Materne O, Beer E, McClung J, Shebani K, Moore F, O'Brien M, Becker JM (2000) NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am J Physiol 279:1298-1306
38. Weinstock JV, Blum A, Metwali A, Elliott D, Bunnett N, Arsenescu R (2003) Substance P regulates Th1-type colitis in IL-10 knockout mice. J Immunol 171:3762-3767
39. Koon HW, Zhao D, Zhan Y, Simeonidis S, Moyer MP, Pothoulakis C (2005) Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase C delta activation. J Pharmacol Exp Ther 314:1393-1400
40. Koon HW, Zhao D, Na X, Moyer MP, Pothoulakis C (2004) Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. J Biol Chem 279:45519-45527
41. Jenkinson KM, Mann PT, Southwell BR, Furness JB (2000) Independent endocytosis of the NK(1) and NK(3) tachykinin receptors in neurons of the rat myenteric plexus. Neuroscience 100:191-199
42. Mann PT, Southwell BR, Ding YQ, Shigemotot R, Mizuno N, Furness JB (1997) Localisation of neurokinin 3 (NK3) receptor immunoreactivity in the rat gastrointestinal tract. Cell Tissue Res 289:1-9
43. Harrington AM, Hutson JM, Southwell BR (2005) Immunohistochemical localization of substance P NK1 receptor in guinea pig distal colon. Neurogastroenterol Motil 17:727-737
44. Portbury AL, Furness JB, Southwell BR, Wong H, Walsh JH, Bunnett NW (1996) Distribution of neurokinin-2 receptors in the guinea-pig gastrointestinal tract. Cell Tissue Res 286(3):281-292
45. Bern MJ, Sturbaum CW, Karayalcin SS, Berschneider HM, Waschman JT, Powell DW (1989) Immune system control of rat and rabbit colonic electrolyte transport. Role of prostaglandins and the enteric nervous system. J Clin Invest 83:1810-1820
46. Martin GR, Wallace JL (2006) Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp Biol Med (Maywood) 231:130-137
47. Zamuner SR, Warrier N, Buret AG, MacNaughton WK, Wallace JL (2003) Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction. Gut 52:1714-1720
48. Cutrufo C, Evangelista S, Cirillo R, Ciucci A, Conte A, Conte B, Lopez G, Manzini S, Maggi CA (1999) Effect of MEN 11467, a new tachykinin NK1 receptor antagonist, in acute rectocolitis induced by acetic acid in guinea-pigs. Eur J Pharmacol 374:277-283
49. Faussone-Pellegrini M-S, Gay J, Vannucchi M-G, Corrsani L, Fioramonti J (2002) Alterations of neurokinin receptors and interstitial cells of cajal during and after jejunal inflammation induced by Nippostrongylus brasiliensis in the rat. Neurogastroenterol Motil 14:83-95
50. Moriarty D, Goldhill J, Selve N, O'Donoghue DP, Baird AW (2001) Human colonic anti-secretory activity of the potent NK(1) antagonist, SR14033: assessment of potential antidiarrhoeal activity in food allergy and inflammatory bowel disease. Br J Pharmacol 133:1346-1354
51. Van Assche G, Noman M, Asnong K, Rutgeerts P (2003) The use of the neurokinin-1 receptor antagonist, SR-140333B, nolpitantium besilate, in mild to moderate active ulcerative colitis. Gastroenterology 124 (Suppl 1):A521
52. Tough IR, Lewis CA, Fozard J, Cox HM (2003) Dual and selective antagonism of neurokinin NK(1) and NK(2) receptor-mediated responses in human colon mucosa. Naunyn Schmiedebergs Arch Pharmacol 367:104-108
53. Reiche D, Jasserand D, Sann H, Preuschoff U, Antel J (2006) Comparison of selective neurokinin receptor antagonists (NK1, NK2, NK3) and mixed profile antagonists (NK1/2, NK1/2/3) in a model of visceral hypersensitivity in rats. Gastroenterology 130 (Suppl 2):A-338